Mereo BioPharma Group

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.

About MREO

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). 

CEO
Denise Vera Scots-Knight
CEODenise Vera Scots-Knight
Employees
36
Employees36
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2015
Founded2015
Employees
36
Employees36

MREO Key Statistics

Market cap
433.49M
Market cap433.49M
Price-Earnings ratio
-12.00
Price-Earnings ratio-12.00
Dividend yield
Dividend yield
Average volume
1.11M
Average volume1.11M
High today
$3.45
High today$3.45
Low today
$3.05
Low today$3.05
Open price
$3.10
Open price$3.10
Volume
2.28M
Volume2.28M
52 Week high
$4.36
52 Week high$4.36
52 Week low
$0.688
52 Week low$0.688
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.